These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 35352998)
21. Sawicki R; Ginalska G Future Med Chem; 2019 Aug; 11(16):2193-2203. PubMed ID: 31538522 [TBL] [Abstract][Full Text] [Related]
22. Mandelic acid-based spirothiazolidinones targeting M. tuberculosis: Synthesis, in vitro and in silico investigations. Trawally M; Demir-Yazıcı K; Dingiş-Birgül Sİ; Kaya K; Akdemir A; Güzel-Akdemir Ö Bioorg Chem; 2022 Apr; 121():105688. PubMed ID: 35189443 [TBL] [Abstract][Full Text] [Related]
23. Lysocin E Targeting Menaquinone in the Membrane of Mycobacterium tuberculosis Is a Promising Lead Compound for Antituberculosis Drugs. Geberetsadik G; Inaizumi A; Nishiyama A; Yamaguchi T; Hamamoto H; Panthee S; Tamaru A; Hayatsu M; Mizutani Y; Kaboso SA; Hakamata M; Ilinov A; Ozeki Y; Tateishi Y; Sekimizu K; Matsumoto S Antimicrob Agents Chemother; 2022 Sep; 66(9):e0017122. PubMed ID: 35969044 [TBL] [Abstract][Full Text] [Related]
24. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Anishetty S; Pulimi M; Pennathur G Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791 [TBL] [Abstract][Full Text] [Related]
25. An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis. Altharawi A; Alossaimi MA; Alanazi MM; Alqahatani SM; Tahir Ul Qamar M Sci Rep; 2023 Apr; 13(1):7014. PubMed ID: 37117557 [TBL] [Abstract][Full Text] [Related]
26. Targeting tuberculosis: a glimpse of promising drug targets. Arora N; Banerjee AK Mini Rev Med Chem; 2012 Mar; 12(3):187-201. PubMed ID: 22356190 [TBL] [Abstract][Full Text] [Related]
27. Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach. Sharma A; Islam MH; Fatima N; Upadhyay TK; Khan MKA; Dwivedi UN; Sharma R Mol Biol Rep; 2019 Apr; 46(2):1715-1725. PubMed ID: 30715689 [TBL] [Abstract][Full Text] [Related]
29. Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis. Tuyiringire N; Deyno S; Weisheit A; Tolo CU; Tusubira D; Munyampundu JP; Ogwang PE; Muvunyi CM; Heyden YV Tuberculosis (Edinb); 2020 Sep; 124():101987. PubMed ID: 32841928 [TBL] [Abstract][Full Text] [Related]
30. Virtual Screening of Small Molecular Inhibitors against DprE1. Zhang G; Guo S; Cui H; Qi J Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447 [TBL] [Abstract][Full Text] [Related]
31. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations. Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488 [TBL] [Abstract][Full Text] [Related]
32. Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis. Rakesh ; Bruhn DF; Scherman MS; Woolhiser LK; Madhura DB; Maddox MM; Singh AP; Lee RB; Hurdle JG; McNeil MR; Lenaerts AJ; Meibohm B; Lee RE PLoS One; 2014; 9(2):e87909. PubMed ID: 24505329 [TBL] [Abstract][Full Text] [Related]
33. In vitro bactericidal activity of 3-cinnamoyl-4-hydroxy-6-methyl-2-pyrone (CHP) against drug-susceptible, drug-resistant and drug-tolerant isolates of Mycobacterium tuberculosis. Bhat ZS; Rather MA; Ul Lah H; Hussain A; Maqbool M; Yousuf SK; Jabeen Z; Wani MA; Ahmad Z J Glob Antimicrob Resist; 2020 Sep; 22():57-62. PubMed ID: 31809940 [TBL] [Abstract][Full Text] [Related]
34. Taira J; Ito T; Nakatani H; Umei T; Baba H; Kawashima S; Maruoka T; Komatsu H; Sakamoto H; Aoki S Int J Mycobacteriol; 2017; 6(2):142-148. PubMed ID: 28559515 [TBL] [Abstract][Full Text] [Related]
35. Novel Antimicrobials from Uncultured Bacteria Acting against Mycobacterium tuberculosis. Quigley J; Peoples A; Sarybaeva A; Hughes D; Ghiglieri M; Achorn C; Desrosiers A; Felix C; Liang L; Malveira S; Millett W; Nitti A; Tran B; Zullo A; Anklin C; Spoering A; Ling LL; Lewis K mBio; 2020 Aug; 11(4):. PubMed ID: 32753498 [No Abstract] [Full Text] [Related]
38. Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione. Khan IH; Patel NB; Patel VM Curr Comput Aided Drug Des; 2018; 14(4):269-283. PubMed ID: 29766819 [TBL] [Abstract][Full Text] [Related]